Hypovitaminosis D association with disease activity in relapsing remitting multiple sclerosis in Brazil

被引:6
|
作者
Becker, Jefferson [1 ]
Callegaro, Dagoberto [2 ]
Lana-Peixoto, Marco Aurelio [3 ]
Talim, Natalia [3 ]
Vidaletti, Tamara [1 ]
Correa, Marcelo de Paula [4 ]
Gomes, Irenio [1 ]
机构
[1] Pontifical Catholic Univ Rio Grande Sul PUCRS, Neuroimmunol Program, Hosp Sao Lucas, Porto Alegre, RS, Brazil
[2] Univ Sao Paulo, Hosp Clin, Multiple Sclerosis Outpatient Clin, BR-05508 Sao Paulo, Brazil
[3] Univ Fed Minas Gerais, Multiple Sclerosis Res Ctr CIEM, Belo Horizonte, MG, Brazil
[4] Fed Univ Itajuba Unifei, Nat Resources Inst, Itajuba, Brazil
关键词
Multiple sclerosis; Demyelinating inflammatory disease; Risk factor; Vitamin D; Hypovitaminosis; MS epidemiology; VITAMIN-D STATUS; RISK; HEALTH;
D O I
10.1016/j.jns.2016.02.064
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Multiple sclerosis (MS) onset is believed to result from a combination of environmental and genetic factors. A prevailing theory addresses the influence of hypovitaminosis D in the development of MS. This research aimed to study the association between vitamin D serum levels and MS, as a prognostic and risk factor for the development and progression of the disease. A cross-sectional multicenter study was conducted in patients with relapsing-remitting MS (n = 67), according to the revised McDonald criteria (2010), accompanied in three MS centers in different Brazilian states. A control group consisted of healthy volunteers (n = 61). Blood collections were carried out in late summer and late winter. This seems to be the first study of this kind in Latin America. The vitamin D serum levels for MS patients (29.63 +/- 8.08) in summer were similar to the controls (29.71 +/- 8.28); however, in winter they were lower than the healthy individuals (24.05 +/- 7.47 vs 26.56 +/- 8.01). No significant difference between the three cities was observed. No association was noted between vitamin D serum levels and gender, race and age, nor correlation of these levels with the EDSS or disease duration. In contrast, a significant association was seen between deficient vitamin D serum levels in late winter with disease activity, characterized by the onset of relapses (19.73 +/- 5.69 vs 25.30 +/- 6.22) or Gd + lesions (17.22 +/- 3.11 vs 22.79 +/- 7.22). (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:236 / 239
页数:4
相关论文
共 50 条
  • [1] The association between disease activity and disability progression in patients with relapsing-remitting multiple sclerosis
    Spelman, T.
    Geale, K.
    Anell, B.
    Hillert, J.
    Wong, S. L.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 127 - 128
  • [2] Cytokine profile in relapsing-remitting multiple sclerosis patients and the association with the progression and the activity of the disease
    Kallaur, Ana Paula
    Oliveira, Sayonara Rangel
    Colado Simao, Andrea Name
    Delicato de Almeida, Elaine Regina
    Morimoto, Helena Kaminami
    Kaimen-Maciel, Damacio Ramon
    Lopes, Josiane
    de Carvalho Jennings Pereira, Wildea Lice
    Andrade, Renato Marques
    Pelegrino, Larissa Muliterno
    Vissoci Reiche, Edna Maria
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1832 - 1832
  • [3] Framingham score, sedentary behaviors, and association with disease activity in relapsing-remitting multiple sclerosis
    D'Amico, E.
    Zanghi, A.
    Ciaorella, M.
    Patti, F.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 339 - 339
  • [4] No evidence of disease activity and cognition in relapsing-remitting multiple sclerosis
    Alonso, R.
    Eizaguirre, B.
    Pita, C.
    Zavala, L.
    Silva, B.
    Marinangeli, A.
    Vanotti, S.
    Garcea, O.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 834 - 834
  • [5] Predictors of Disease Activity and Worsening in Relapsing-Remitting Multiple Sclerosis
    Zhang, Yinan
    Cofield, Stacey
    Cutter, Gary
    Krieger, Stephen
    Wolinsky, Jerry S.
    Lublin, Fred
    NEUROLOGY-CLINICAL PRACTICE, 2022, 12 (04) : E58 - E65
  • [6] Cerebrovascular reactivity and disease activity in relapsing-remitting multiple sclerosis
    Smolinski, Lukasz
    Litwin, Tomasz
    Kruk, Karolina
    Skowronska, Marta
    Kurkowska-Jastrzebska, Iwona
    Czlonkowska, Anna
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 29 (02): : 183 - 188
  • [7] Cytokine profile in relapsing-remitting multiple sclerosis patients and the association between progression and activity of the disease
    Kallaur, Ana Paula
    Oliveira, Sayonara Rangel
    Colado Simao, Andrea Name
    Delicato De Almeida, Elaine Regina
    Morimoto, Helena Kaminami
    Lopes, Josiane
    De Carvalho Jennings Pereira, Wildea Lice
    Andrade, Renato Marques
    Pelegrino, Larissa Muliterno
    Borelli, Sueli Donizete
    Kaimen-Maciel, Damacio Ramon
    Vissoci Reiche, Edna Maria
    MOLECULAR MEDICINE REPORTS, 2013, 7 (03) : 1010 - 1020
  • [8] Association of the retinal vasculature and disease course in patients with relapsing remitting multiple sclerosis
    Noll, C.
    Aly, L.
    Wicklein, R.
    Berthele, A.
    Mardin, C.
    Korn, T.
    Hemmer, B.
    Knier, B.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 570 - 571
  • [9] Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis
    Prosperini, Luca
    Mancinelli, Chiara
    Haggiag, Shalom
    Cordioli, Cinzia
    De Giglio, Laura
    De Rossi, Nicola
    Galgani, Simonetta
    Rasia, Sarah
    Ruggieri, Serena
    Tortorella, Carla
    Pozzilli, Carlo
    Gasperini, Claudio
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2020, 91 (03): : 271 - 277
  • [10] A pilot study of monocytes in relapsing remitting multiple sclerosis: Correlation with disease activity
    Taha, Sara, I
    Mohamed, Hala Ghareeb
    Mamdouh, Rasha
    Kamal, Nada E.
    Khater, Shaimaa Sayed
    INNATE IMMUNITY, 2024, 30 (05) : 90 - 95